US20020066691A1 - Therapy pack - Google Patents
Therapy pack Download PDFInfo
- Publication number
- US20020066691A1 US20020066691A1 US09/729,230 US72923000A US2002066691A1 US 20020066691 A1 US20020066691 A1 US 20020066691A1 US 72923000 A US72923000 A US 72923000A US 2002066691 A1 US2002066691 A1 US 2002066691A1
- Authority
- US
- United States
- Prior art keywords
- blister
- etodolac
- cells
- therapy pack
- indicia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D73/00—Packages comprising articles attached to cards, sheets or webs
- B65D73/0035—Packages comprising articles attached to cards, sheets or webs the articles being retained within a recess or a series of recesses provided in a single card
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/52—Details
- B65D75/54—Cards, coupons, or other inserts or accessories
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
Definitions
- the field of the present invention relates generally to the packaging of tablet form medications, and more particularly to packaging for dispensing tablets and/or capsules in a controlled manner for the combined oral dose of a muscle relaxant drug, and a nonsteroidal anti-inflammatory drug (NSAID).
- NSAID nonsteroidal anti-inflammatory drug
- Cyclobenzaprine HCl a muscle relaxant drug manufactured and sold by Merck & Co., Inc., West Point, Pa., under the brand name Flexeril®, is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful, musculoskeletal conditions. More specifically, this drug relieves skeletal muscle spasm of local origin without interfering with muscle function. Specifically, it is typically used for periods of two or three weeks in view of the typical duration of muscle spasm associated with acute, painful, musculoskeletal conditions.
- Etodolac manufactured and sold by Ayerst Laboratories, Inc., Philadelphia, Pa., under the brand name Lodine®, is indicated for acute and long-term use in the management of signs and symptoms of osteoarthritis, and also for the management of pain.
- This drug is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activity.
- NSAID nonsteroidal anti-inflammatory drug
- the present inventor compiled data of prescription use for the twelve month period ending November 1999, illustrating the use of Lodine® 154,000 times as concomitant therapy with Flexeril®.
- This data shows that physicians in private practice frequently prescribe use of the aforesaid products together in a combined therapy, requiring the physician to write two separate prescriptions, for each product, respectively.
- the present inventor recognized that both physicians and a substantial number of patients who received separate prescriptions for these products, namely cyclobenzaprine and etodolac, would benefit from a packaging product that would permit only one prescription to be required, and would enhance the likelihood of patient compliance to thereby improve the physician's management of symptoms being treated.
- this invention is not limited to the aforesaid specific drugs, and is meant to cover any combined therapy consisting of a muscle relaxant drug, and an NSAID.
- An object of the invention is to provide a packaging system providing combined daily oral doses of a muscle relaxant drug, and an NSAID.
- Another object of the invention is to provide a packaging system that permits cyclobenzaprine hydrochloride tablets, and etodolac capsules or tablets to be dispensed together in a prescribed dosage regimen.
- a co-packaging system includes a dispensing carton containing ten blister cards.
- Each blister card includes one or more sets of blister cells, with each set containing two cells, with one cell thereof containing a prescribed dose of a muscle relaxant drug such as but not limited to a cyclobenzaprine hydrochloride tablet, and the associated neighboring cell containing a prescribed dose of an NSAID such as but not limited to etodolac, in capsule or tablet form, for example.
- a muscle relaxant drug such as but not limited to a cyclobenzaprine hydrochloride tablet
- an NSAID such as but not limited to etodolac
- Indicia is imprinted on each blister card for instructing a patient when to take a given combined dose of these drugs.
- the ten blister cards provide a typical ten day prescribed dosage.
- the number of blister cards can be increased or decreased to accommodate other prescribed dosing periods, such as a two or three week period, for example.
- FIG. 1 shows one embodiment of the invention for providing a carton containing a plurality of blister packs
- FIG. 2 shows an embodiment of the invention for a blister pack providing a single day dosage, with each dosage comprising the combined cyclobenzaprine hydrochloride tablet with an etodolac capsule or tablet.
- FIGS. 1 and 2 The embodiment illustrated herein includes a carton 1 containing a predetermined number of individual blister packs 3 , for providing a prescribed total dosage therapy.
- Each blister pack 3 includes three paired doses 5 , 7 , and 9 , for example a paired morning, afternoon, and bedtime dose, respectively, as shown.
- a prescribed strength of cyclobenzaprine hydrochloride tablet 11 is combined with a prescribed dose or strength of etodolac capsule or tablet 13 .
- each blister card 3 for daily use contains three tablets 11 of cyclobenzaprine hydrochloride tablets having a strength of 10 milligrams (mg), and three each of etodolac capsules or tablets of 330 mg strength, respectively.
- Such a combination of tablet dosage strengths corresponds to current prescribing practices, but is not meant to be limiting, and can be changed according to different prescribing practices.
- each tablet or capsule 11 , 13 is contained in a blister cell or cavity 12 as is known in the art.
- the maximum recommended daily dosage for etodolac is 1000 mg (milligrams).
- the use of 330 mg strength etodolac capsules or tablets 13 will substantially provide for the recommended daily dosage thereof.
- the individual combined dose of 330 mg of etodolac satisfies the therapeutic requirement of physicians treating acute musculoskeletal injuries, combined with a 10 mg dose of cyclobenzaprine, as a rational therapeutic combination for the adjunctive treatment of acute painful musculoskeletal injuries.
- Each blister card 3 is self instructing for a patient's use, and as indicated above, the number of blister packs can be varied to accommodate the number of days of desired treatment.
- the instructions are in the form of printed indicia, namely “MORNING”, “AFTERNOON”, and “BEDTIME”, positioned as shown in this example, between associated pairs of blister cells in rows 5 , 7 , and 9 , respectively.
- the column of blister cells 12 containing cyclobenzaprine tablets 11 is labeled “Cyclobenzaprine 10 mg”
- the column of blister cells 12 containing etodolac tablets or capsules is labeled “Etodolac 330 mg”, as shown.
Abstract
Description
- The field of the present invention relates generally to the packaging of tablet form medications, and more particularly to packaging for dispensing tablets and/or capsules in a controlled manner for the combined oral dose of a muscle relaxant drug, and a nonsteroidal anti-inflammatory drug (NSAID).
- Cyclobenzaprine HCl, a muscle relaxant drug manufactured and sold by Merck & Co., Inc., West Point, Pa., under the brand name Flexeril®, is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful, musculoskeletal conditions. More specifically, this drug relieves skeletal muscle spasm of local origin without interfering with muscle function. Specifically, it is typically used for periods of two or three weeks in view of the typical duration of muscle spasm associated with acute, painful, musculoskeletal conditions.
- Etodolac, manufactured and sold by Ayerst Laboratories, Inc., Philadelphia, Pa., under the brand name Lodine®, is indicated for acute and long-term use in the management of signs and symptoms of osteoarthritis, and also for the management of pain. This drug is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activity.
- The present inventor compiled data of prescription use for the twelve month period ending November 1999, illustrating the use of Lodine® 154,000 times as concomitant therapy with Flexeril®. This data shows that physicians in private practice frequently prescribe use of the aforesaid products together in a combined therapy, requiring the physician to write two separate prescriptions, for each product, respectively. The present inventor recognized that both physicians and a substantial number of patients who received separate prescriptions for these products, namely cyclobenzaprine and etodolac, would benefit from a packaging product that would permit only one prescription to be required, and would enhance the likelihood of patient compliance to thereby improve the physician's management of symptoms being treated. However, this invention is not limited to the aforesaid specific drugs, and is meant to cover any combined therapy consisting of a muscle relaxant drug, and an NSAID.
- An object of the invention is to provide a packaging system providing combined daily oral doses of a muscle relaxant drug, and an NSAID.
- Another object of the invention is to provide a packaging system that permits cyclobenzaprine hydrochloride tablets, and etodolac capsules or tablets to be dispensed together in a prescribed dosage regimen.
- With this and other objects in mind, in one embodiment of the invention, a co-packaging system includes a dispensing carton containing ten blister cards. Each blister card includes one or more sets of blister cells, with each set containing two cells, with one cell thereof containing a prescribed dose of a muscle relaxant drug such as but not limited to a cyclobenzaprine hydrochloride tablet, and the associated neighboring cell containing a prescribed dose of an NSAID such as but not limited to etodolac, in capsule or tablet form, for example. Each blister card includes the required number of sets of blister cells for containing the number of doses of these drugs required over a 24 hour period. Indicia is imprinted on each blister card for instructing a patient when to take a given combined dose of these drugs. The ten blister cards provide a typical ten day prescribed dosage. In other embodiments of the invention, the number of blister cards can be increased or decreased to accommodate other prescribed dosing periods, such as a two or three week period, for example.
- Various embodiments of the present invention are described in detail below with reference to the drawings, in which like items are indicated by the same reference designation, wherein:
- FIG. 1 shows one embodiment of the invention for providing a carton containing a plurality of blister packs; and
- FIG. 2 shows an embodiment of the invention for a blister pack providing a single day dosage, with each dosage comprising the combined cyclobenzaprine hydrochloride tablet with an etodolac capsule or tablet.
- Various embodiments of the present invention will be described in detail with reference to FIGS. 1 and 2. The embodiment illustrated herein includes a carton1 containing a predetermined number of
individual blister packs 3, for providing a prescribed total dosage therapy. Eachblister pack 3 includes three paireddoses tablet 13. In a typical recommended therapy, eachblister card 3 for daily use contains three tablets 11 of cyclobenzaprine hydrochloride tablets having a strength of 10 milligrams (mg), and three each of etodolac capsules or tablets of 330 mg strength, respectively. Such a combination of tablet dosage strengths corresponds to current prescribing practices, but is not meant to be limiting, and can be changed according to different prescribing practices. Note that for eachblister card 3, in this example, each tablet orcapsule 11, 13 is contained in a blister cell orcavity 12 as is known in the art. - Presently, the maximum recommended daily dosage for etodolac is 1000 mg (milligrams). Therefor, the use of 330 mg strength etodolac capsules or
tablets 13 will substantially provide for the recommended daily dosage thereof. In summary, for eachblister card 3, the individual combined dose of 330 mg of etodolac satisfies the therapeutic requirement of physicians treating acute musculoskeletal injuries, combined with a 10 mg dose of cyclobenzaprine, as a rational therapeutic combination for the adjunctive treatment of acute painful musculoskeletal injuries. Eachblister card 3 is self instructing for a patient's use, and as indicated above, the number of blister packs can be varied to accommodate the number of days of desired treatment. In this example, the instructions are in the form of printed indicia, namely “MORNING”, “AFTERNOON”, and “BEDTIME”, positioned as shown in this example, between associated pairs of blister cells inrows blister cells 12 containing cyclobenzaprine tablets 11 is labeled “Cyclobenzaprine 10 mg”, and the column ofblister cells 12 containing etodolac tablets or capsules is labeled “Etodolac 330 mg”, as shown. - Although various embodiments of the invention have been shown and described, they are not meant to be limiting. Those of ordinary skill in the art may recognize various modifications to these embodiments, which modifications are meant to be covered by the spirit and scope of the appended claims.
Claims (30)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/729,230 US20020066691A1 (en) | 2000-12-04 | 2000-12-04 | Therapy pack |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/729,230 US20020066691A1 (en) | 2000-12-04 | 2000-12-04 | Therapy pack |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020066691A1 true US20020066691A1 (en) | 2002-06-06 |
Family
ID=24930114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/729,230 Abandoned US20020066691A1 (en) | 2000-12-04 | 2000-12-04 | Therapy pack |
Country Status (1)
Country | Link |
---|---|
US (1) | US20020066691A1 (en) |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030075172A1 (en) * | 2001-10-19 | 2003-04-24 | Johnson Keith A. | Method and apparatus for dispensing inhalator medicament |
US20040188316A1 (en) * | 2003-03-26 | 2004-09-30 | The Procter & Gamble Company | Kit for pharmaceutical use |
US20050056564A1 (en) * | 2003-09-16 | 2005-03-17 | John Higgins | Wallet pill card |
US20060169601A1 (en) * | 2003-12-23 | 2006-08-03 | Lyon Stephen C | Medicinal container |
US20070250346A1 (en) * | 2005-09-30 | 2007-10-25 | Luciano Robert A Jr | System and method for processing a multiple prescription order |
US20070251852A1 (en) * | 2006-04-28 | 2007-11-01 | David Purdy | Multiple medication package |
EP2034829A1 (en) * | 2006-06-08 | 2009-03-18 | Incrementha PD&I - Pesquisa, Desenvolvimento e Inovação de Fármacos e Medicamentos Ltda. | Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association |
US20090321296A1 (en) * | 2004-10-01 | 2009-12-31 | Luciano Jr Robert A | Tablet Dispensing Container |
US20100069213A1 (en) * | 2004-10-01 | 2010-03-18 | Luciano Jr Robert A | Manufacturing Separable Pouches With A Center Cut Blade |
US20100136104A1 (en) * | 2005-08-04 | 2010-06-03 | Squashic Steven A | Nutritional supplement for use under physiologically stressful conditions |
US20100145500A1 (en) * | 2005-09-30 | 2010-06-10 | Luciano Jr Robert A | Multiple prescription production facility |
US20100153130A1 (en) * | 2004-10-01 | 2010-06-17 | Edge Technology | System and Method for Placing a Multiple Tablet Order Online |
US20100228562A1 (en) * | 2004-10-01 | 2010-09-09 | Edge Technology | System and Method for Verifying and Assembling a Multiple Prescription Package |
US20110101016A1 (en) * | 2009-09-25 | 2011-05-05 | Edge Medical Properties, Llc | Low vision patient compliant medication management system and method |
US20110100863A1 (en) * | 2004-10-01 | 2011-05-05 | Edge Medical Properties, Llc | Dual dispensing tablet container |
US20110203949A1 (en) * | 2008-11-03 | 2011-08-25 | Mohammed Ridha Chakroun | Contraception kit |
US8197854B2 (en) | 2005-08-04 | 2012-06-12 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US20120152796A1 (en) * | 2010-12-17 | 2012-06-21 | Rosa Manuela Leon Alonso | Blister Cards Promoting Intuitive Dosing |
US20120152795A1 (en) * | 2010-12-17 | 2012-06-21 | The Procter & Gamble Company | Blister Cards Promoting Intuitive Dosing |
US8263137B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US20120305584A1 (en) * | 2011-06-06 | 2012-12-06 | Omnicare Inc. | Administration methods and packagings for oral medications |
US8712582B1 (en) | 2004-10-01 | 2014-04-29 | Edge Medical Properties, Llc | System and method for combining different tablets into a pouch |
US8914298B1 (en) | 2004-10-01 | 2014-12-16 | Edge Medical Properties, Llc | System and method for integrated verification and assembly of multi-script pouches into a housing container |
US8972288B2 (en) | 2004-10-01 | 2015-03-03 | Edge Medical Properties, Llc | System and method for online matrix-based dosage scheduling |
US9015058B2 (en) | 2004-10-01 | 2015-04-21 | Edge Medical Properties, Llc | Matrix based dosage scheduling |
US9141764B2 (en) | 2010-11-12 | 2015-09-22 | Edge Medical Properties, Llc | System and method for online integrated multiple tablet ordering |
US9238518B2 (en) | 2004-10-01 | 2016-01-19 | Edge Medical Properties, Llc | Inspection system and method with a control process that inspects different medications |
US9334096B2 (en) | 2004-10-01 | 2016-05-10 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
US9428314B2 (en) | 2004-10-01 | 2016-08-30 | Edge Medical Properties, Llc | Pill assembly for pill packaging and delivery systems |
US9445970B2 (en) | 2010-12-17 | 2016-09-20 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
US10315450B1 (en) | 2006-10-24 | 2019-06-11 | Edge Medical Properties, Llc | System and method for generating an integrated label for container housing multi-script pouches |
EP3536299A1 (en) * | 2018-03-05 | 2019-09-11 | Distraimed | Drug delivery device for therapeutic treatment of a single patient |
US10435192B2 (en) | 2011-05-16 | 2019-10-08 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
US10836197B2 (en) | 2004-10-01 | 2020-11-17 | Edge Medical Properties, Llc | System and method for generating an integrated label for container housing multi-script pouches |
-
2000
- 2000-12-04 US US09/729,230 patent/US20020066691A1/en not_active Abandoned
Cited By (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030075172A1 (en) * | 2001-10-19 | 2003-04-24 | Johnson Keith A. | Method and apparatus for dispensing inhalator medicament |
US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
US20040188316A1 (en) * | 2003-03-26 | 2004-09-30 | The Procter & Gamble Company | Kit for pharmaceutical use |
WO2004087038A1 (en) * | 2003-03-26 | 2004-10-14 | The Procter & Gamble Company | Kit for pharmaceutical use |
HRP20050824B1 (en) * | 2003-03-26 | 2014-01-17 | Warner Chilcott Company, Llc | Kit for pharmaceutical use |
KR100775795B1 (en) * | 2003-03-26 | 2007-11-12 | 더 프록터 앤드 갬블 캄파니 | Kit for pharmaceutical use |
US20050056564A1 (en) * | 2003-09-16 | 2005-03-17 | John Higgins | Wallet pill card |
US20060169601A1 (en) * | 2003-12-23 | 2006-08-03 | Lyon Stephen C | Medicinal container |
US20100153130A1 (en) * | 2004-10-01 | 2010-06-17 | Edge Technology | System and Method for Placing a Multiple Tablet Order Online |
US10836197B2 (en) | 2004-10-01 | 2020-11-17 | Edge Medical Properties, Llc | System and method for generating an integrated label for container housing multi-script pouches |
US20090321296A1 (en) * | 2004-10-01 | 2009-12-31 | Luciano Jr Robert A | Tablet Dispensing Container |
US20100069213A1 (en) * | 2004-10-01 | 2010-03-18 | Luciano Jr Robert A | Manufacturing Separable Pouches With A Center Cut Blade |
US9428314B2 (en) | 2004-10-01 | 2016-08-30 | Edge Medical Properties, Llc | Pill assembly for pill packaging and delivery systems |
US9245304B2 (en) | 2004-10-01 | 2016-01-26 | Edge Medical Properties, Llc | Manufacturing separable pouches with a center cut blade |
US9454788B2 (en) | 2004-10-01 | 2016-09-27 | Edge Medical Properties, Llc | System and method for placing a multiple tablet order online |
US20100147734A1 (en) * | 2004-10-01 | 2010-06-17 | Edge Technology | User Selectable Multiple Tablet Package |
US20100228562A1 (en) * | 2004-10-01 | 2010-09-09 | Edge Technology | System and Method for Verifying and Assembling a Multiple Prescription Package |
US9334096B2 (en) | 2004-10-01 | 2016-05-10 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
US9238518B2 (en) | 2004-10-01 | 2016-01-19 | Edge Medical Properties, Llc | Inspection system and method with a control process that inspects different medications |
US20110100863A1 (en) * | 2004-10-01 | 2011-05-05 | Edge Medical Properties, Llc | Dual dispensing tablet container |
US9015058B2 (en) | 2004-10-01 | 2015-04-21 | Edge Medical Properties, Llc | Matrix based dosage scheduling |
US8146747B2 (en) * | 2004-10-01 | 2012-04-03 | Edge Medical Properties, Llc | Tablet dispensing container |
US8972288B2 (en) | 2004-10-01 | 2015-03-03 | Edge Medical Properties, Llc | System and method for online matrix-based dosage scheduling |
US8931241B2 (en) | 2004-10-01 | 2015-01-13 | Edge Medical Properties, Llc | System and method for assembling a multiple prescription package |
US8914298B1 (en) | 2004-10-01 | 2014-12-16 | Edge Medical Properties, Llc | System and method for integrated verification and assembly of multi-script pouches into a housing container |
US8789700B2 (en) | 2004-10-01 | 2014-07-29 | Edge Medical Properties, Llc | System and method for communicating and inspecting a multiple tablet order |
US8713897B2 (en) | 2004-10-01 | 2014-05-06 | Edge Medical Properties, Llc | Method and system for verifying a filled prescription order |
US8712582B1 (en) | 2004-10-01 | 2014-04-29 | Edge Medical Properties, Llc | System and method for combining different tablets into a pouch |
US20100136104A1 (en) * | 2005-08-04 | 2010-06-03 | Squashic Steven A | Nutritional supplement for use under physiologically stressful conditions |
US8202546B2 (en) | 2005-08-04 | 2012-06-19 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US8263137B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US8263667B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US8197854B2 (en) | 2005-08-04 | 2012-06-12 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US20070250346A1 (en) * | 2005-09-30 | 2007-10-25 | Luciano Robert A Jr | System and method for processing a multiple prescription order |
US8777012B2 (en) | 2005-09-30 | 2014-07-15 | Edge Medical Properties, Llc | System and method for processing a multiple tablet order |
US20100145500A1 (en) * | 2005-09-30 | 2010-06-10 | Luciano Jr Robert A | Multiple prescription production facility |
US9710866B2 (en) | 2005-09-30 | 2017-07-18 | Edge Medical, Llc | System and method for processing a multiple prescription order |
US20070251852A1 (en) * | 2006-04-28 | 2007-11-01 | David Purdy | Multiple medication package |
EP2034829A4 (en) * | 2006-06-08 | 2009-12-02 | Incrementha P D & I Pesquisa Desenvolvimento E Inovacao De Farmacos E Medicamentos Ltda | Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association |
EP2034829A1 (en) * | 2006-06-08 | 2009-03-18 | Incrementha PD&I - Pesquisa, Desenvolvimento e Inovação de Fármacos e Medicamentos Ltda. | Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association |
US10315450B1 (en) | 2006-10-24 | 2019-06-11 | Edge Medical Properties, Llc | System and method for generating an integrated label for container housing multi-script pouches |
US20110203949A1 (en) * | 2008-11-03 | 2011-08-25 | Mohammed Ridha Chakroun | Contraception kit |
US8777014B2 (en) * | 2008-11-03 | 2014-07-15 | Mohammed Ridha Chakroun | Contraception kit |
US20110101016A1 (en) * | 2009-09-25 | 2011-05-05 | Edge Medical Properties, Llc | Low vision patient compliant medication management system and method |
US9141764B2 (en) | 2010-11-12 | 2015-09-22 | Edge Medical Properties, Llc | System and method for online integrated multiple tablet ordering |
US20120152795A1 (en) * | 2010-12-17 | 2012-06-21 | The Procter & Gamble Company | Blister Cards Promoting Intuitive Dosing |
US9314402B2 (en) | 2010-12-17 | 2016-04-19 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
US9445970B2 (en) | 2010-12-17 | 2016-09-20 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
US20120152796A1 (en) * | 2010-12-17 | 2012-06-21 | Rosa Manuela Leon Alonso | Blister Cards Promoting Intuitive Dosing |
US9526673B2 (en) | 2010-12-17 | 2016-12-27 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
US8905237B2 (en) * | 2010-12-17 | 2014-12-09 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
US8752704B2 (en) * | 2010-12-17 | 2014-06-17 | The Procter & Gamble Company | Blister cards promoting intuitive dosing |
US10435192B2 (en) | 2011-05-16 | 2019-10-08 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
US20120305584A1 (en) * | 2011-06-06 | 2012-12-06 | Omnicare Inc. | Administration methods and packagings for oral medications |
EP3536299A1 (en) * | 2018-03-05 | 2019-09-11 | Distraimed | Drug delivery device for therapeutic treatment of a single patient |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020066691A1 (en) | Therapy pack | |
US6077530A (en) | Analgesic dosage units for coordinated administration | |
US7422110B2 (en) | Titration/compliance pack with increasing doses | |
US6270796B1 (en) | Antihistamine/decongestant regimens for treating rhinitis | |
US7556150B2 (en) | Dispenser for progestin used for acute and maintenance treatment of DUB | |
US9408777B2 (en) | Blister package for patient compliance | |
US6651816B2 (en) | Antihistamine/decongestant regimens for treating rhinitis | |
US5597072A (en) | Totally interactive patient compliance method | |
US6293403B1 (en) | Vitamin organizing, storing and dispensing system | |
CA2378378A1 (en) | Strip pack | |
US20070138048A1 (en) | Modular pill case with separable pill-holding members | |
US10143627B2 (en) | Compliance system | |
Murray | Evaluation of aspirin in treatment of headache | |
Spriet et al. | Adherence of elderly patients to treatment with pentoxifylline | |
GB2228922A (en) | Packaging drugs | |
Löfdahl | Compliance as a factor in the development of nitrate tolerance: a patient investigation | |
Fincham | Methods to Impact Patient Compliance | |
US20210375463A1 (en) | Method and device for preventing microbial resistance | |
US20040171992A1 (en) | Cream dispenser providing sequential dispensing means | |
RU94457U1 (en) | PACKING OF THE DAILY DOSAGE OF MEDICINES FOR ORAL USE FOR INTEGRATED MEDICINE THERAPY (OPTIONS) AND PACKING OF MEDICINES FOR ORAL USE FOR THE COURSE OF COMPLEX MEDICA | |
JP2024510484A (en) | Formulation administration system | |
López-Pintor et al. | THE IMPACT OF CHANGES IN PILL APPEARANCE ON THE ADHERENCE TO MEDICATION | |
RU99113019A (en) | PACKING ENSURING COMPLIANCE WITH PRESCRIPTIONS AND METHOD FOR PROMOTING OR IMPROVING PATIENT'S COMPLIANCE WITH PRESCRIPTIONS OF COMPREHENSIVE MEDICINAL TREATMENT | |
Mamis | Here's how I do it: Prescription forms | |
MXPA06007146A (en) | Patient specific medication dispenser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CARTER-WALLACE, INC., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VARON, STEVEN;REEL/FRAME:011587/0957 Effective date: 20001204 |
|
AS | Assignment |
Owner name: LEHMAN COMMERCIAL PAPER INC., NEW JERSEY Free format text: SECURITY AGREEMENT;ASSIGNORS:MEDPOINT INC.;MCC ACQUISITION SUB CORPORATION;MCC MERGER SUB CORPORATION;REEL/FRAME:012530/0854 Effective date: 20010928 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: MEDPOINTE HEALTHCARE INC., NEW JERSEY Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:LEHMAN COMMERICAL PAPER INC.;REEL/FRAME:017675/0384 Effective date: 20060524 |